From targeted therapy to a novel way: Immunogenic cell death in lung cancer.

Xu, Jiawei; Xiong, Yiyi; Xu, Zhou; Xing, Hongquan; Zhou, Lingyun; Zhang, Xinyi

Xu, Jiawei; Xiong, Yiyi; Xu, Zhou; Xing, Hongquan; Zhou, Lingyun; Zhang, Xinyi.

Afiliação

Xu J; Department of Respiratory Diseases, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Xiong Y; The Second Clinical Medical College of Nanchang University, Nanchang, China.
Xu Z; The Second Clinical Medical College of Nanchang University, Nanchang, China.
Xing H; The Second Clinical Medical College of Nanchang University, Nanchang, China.
Zhou L; Department of Respiratory Diseases, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Zhang X; The Second Clinical Medical College of Nanchang University, Nanchang, China.

Front Med (Lausanne) ; 9: 1102550, 2022.

Article em En | MEDLINE | ID: mdl-36619616

Palavras-chave

damage-associated molecular patterns; genetic alteration; immunogenic cell death; immunotherapy; lung cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Med (Lausanne) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google